|
|
Other links at Articles > Cardiology |
| 2. |
Negative FIRE Trial Retains Flicker of Hope
|
|
|
An exploratory phase 2 trial of a new small peptide compound, FX06, designed to cut reperfusion injury in STEMI patients, has failed to show a benefit on the primary end point. But the investigators are still planning a larger trial, convinced that the agent holds promise. Heartwire
|
| 4. |
Oncology Research Busy, With More Trials Than Other Therapeutic Areas
|
|
|
Over the 2-year study period, oncology, endocrinology, and rheumatology had more registered study protocols in the second year than the first, whereas studies in cardiology declined from 346 registered protocols in year 1 to 257 registered studies in the second year. Medscape Medical News
|
|
|